Supporting CAR T-Cell Development with a Translational Biomarker Strategy

Biomarkers play a critical part in reducing scientific, regulatory and commercial risks and accelerating CAR T-cell development. This presentation delves into the importance of a translational biomarker strategy in assessing safety and efficacy to navigate regulatory pathways in rapid development of CAR T-cell therapies.